US2021285045A1PendingUtilityA1
Transposition of Native Chromatin for Personal Epigenomics
Assignee: UNIV LELAND STANFORD JUNIORPriority: May 23, 2013Filed: Dec 7, 2020Published: Sep 16, 2021
Est. expiryMay 23, 2033(~6.9 yrs left)· nominal 20-yr term from priority
C12Q 1/6806C12Q 1/6874Y02A90/10G16H 50/20C12Q 1/6869C12Q 2537/164G16B 20/00C12Q 2521/301G16B 30/00
77
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Provided herein is a method for analyzing polynucleotides such as genomic DNA. In certain embodiments, the method comprises: (a) treating chromatin isolated from a population of cells with an insertional enzyme complex to produce tagged fragments of genomic DNA; (b) sequencing a portion of the tagged fragments to produce a plurality of sequence reads; and (c) making an epigenetic map of a region of the genome of the cells by mapping information obtained from the sequence reads to the region. A kit for performing the method is also provided.
Claims
exact text as granted — not AI-modified1 .- 30 . (canceled)
31 . A composition comprising:
an insertional enzyme complex comprising a transposase enzyme; and a plurality of tagged nucleic acid fragments derived from one or more regions of open chromatin, wherein said insertional enzyme complex does not comprise an antibody specific to a protein that is part of said chromatin.
32 . The composition of claim 31 , further comprising a plurality of divalent cations.
33 . The composition of claim 32 , wherein the plurality of divalent cations are not chelated.
34 . The composition of claim 32 , wherein the plurality of divalent cations are selected from the group consisting of: magnesium, manganese, or any combination thereof.
35 . The composition of claim 31 , wherein the transposase is a Tn transposase.
36 . The composition of claim 35 , wherein the Tn transposase is a Tn5 transposase.
37 . The composition of claim 31 , wherein the plurality of tagged nucleic acid fragments correspond to two or more regions of a genome.
38 . The composition of claim 31 , wherein the plurality of tagged nucleic acid fragments correspond to at least 1,000 regions of a genome.
39 . The composition of claim 31 , wherein the plurality of tagged nucleic acid fragments correspond to genome-wide regions of open chromatin.
40 . The composition of claim 31 , wherein the insertional enzyme complex is contained within a permeabilized cell nucleus.
41 . The composition of claim 40 , wherein the permeabilized cell nucleus is isolated from a cell.
42 . The composition of claim 40 , wherein the permeabilized cell nucleus is contained within a cell.
43 . A composition comprising:
an insertional enzyme complex comprising a transposase enzyme; and a plurality of tagged nucleic acid fragments derived from one or more regions of open chromatin, wherein the plurality of tagged nucleic acid fragments correspond to genome-wide regions of open chromatin.
44 . The composition of claim 43 , further comprising a plurality of divalent cations.
45 . The composition of claim 44 , wherein the plurality of divalent cations are not chelated.
46 . The composition of claim 44 , wherein the plurality of divalent cations are selected from the group consisting of: magnesium, manganese, or any combination thereof.
47 . The composition of claim 43 , wherein the transposase is a Tn transposase.
48 . The composition of claim 47 , wherein the Tn transposase is a Tn5 transposase.
49 . The composition of claim 43 , wherein the insertional enzyme complex is contained within a permeabilized cell nucleus.
50 . The composition of claim 49 , wherein the permeabilized cell nucleus is isolated from a cell.
51 . The composition of claim 49 , wherein the permeabilized cell nucleus is contained within a cell.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.